Tufail Yusuf, Cook Daniela, Fourgeaud Lawrence, Powers Colin J, Merten Katharina, Clark Charles L, Hoffman Elizabeth, Ngo Alexander, Sekiguchi Kohei J, O'Shea Clodagh C, Lemke Greg, Nimmerjahn Axel
Waitt Advanced Biophotonics Center, The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA.
Molecular Neurobiology Laboratory, The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA.
Neuron. 2017 Feb 8;93(3):574-586.e8. doi: 10.1016/j.neuron.2016.12.021. Epub 2017 Jan 19.
Microglia are the intrinsic immune sentinels of the central nervous system. Their activation restricts tissue injury and pathogen spread, but in some settings, including viral infection, this response can contribute to cell death and disease. Identifying mechanisms that control microglial responses is therefore an important objective. Using replication-incompetent adenovirus 5 (Ad5)-based vectors as a model, we investigated the mechanisms through which microglia recognize and respond to viral uptake. Transgenic, immunohistochemical, molecular-genetic, and fluorescence imaging approaches revealed that phosphatidylserine (PtdSer) exposure on the outer leaflet of transduced cells triggers their engulfment by microglia through TAM receptor-dependent mechanisms. We show that inhibition of phospholipid scramblase 1 (PLSCR1) activity reduces intracellular calcium dysregulation, prevents PtdSer externalization, and enables months-long protection of vector-transduced, transgene-expressing cells from microglial phagocytosis. Our study identifies PLSCR1 as a potent target through which the innate immune response to viral vectors, and potentially other stimuli, may be controlled.
小胶质细胞是中枢神经系统的固有免疫哨兵。它们的激活可限制组织损伤和病原体传播,但在某些情况下,包括病毒感染,这种反应可能导致细胞死亡和疾病。因此,确定控制小胶质细胞反应的机制是一个重要目标。我们以基于复制缺陷型腺病毒5(Ad5)的载体为模型,研究了小胶质细胞识别和响应病毒摄取的机制。转基因、免疫组织化学、分子遗传学和荧光成像方法显示,转导细胞外膜上磷脂酰丝氨酸(PtdSer)的暴露通过TAM受体依赖性机制触发小胶质细胞对它们的吞噬。我们表明,抑制磷脂翻转酶1(PLSCR1)的活性可减少细胞内钙失调,防止PtdSer外化,并使载体转导、表达转基因的细胞免受小胶质细胞吞噬长达数月之久。我们的研究确定PLSCR1是一个有效的靶点,通过它可以控制对病毒载体以及可能对其他刺激的先天免疫反应。